Moreover, it needs to conduct further research on larger cohorts, different races and even the international multicenters to investigate and confirm the association between these CD44 SNPs and clinicopathological characteristics patients with lung adenocarcinoma. The gene discussed is CD44; the disease is lung adenocarcinoma.